Your own cells, reborn: a new hope for Parkinson's?
Disease control
ENROLLING_BY_INVITATION
This early-stage trial tests the safety of a new treatment called ANPD001 for people with Parkinson's disease. The treatment uses a patient's own skin cells to create new dopamine-producing cells, which are then injected into the brain. The study involves 9 participants and aims …
Phase: PHASE1 • Sponsor: Aspen Neuroscience • Aim: Disease control
Last updated May 17, 2026 03:32 UTC